Skip to main content

Animations

MJFF Publications

3151 - 3160 of 8819 Results
Title
Year
  • Year
  • 2015
  • 2017
  • 2012
  • 2015
  • 2011
  • 2014
  • 2011
  • 2011
  • 2012
  • 2008
  • Summary Details
    OPEN
    Title: GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26359
    Citation Count: 189
  • Summary Details
    OPEN
    Title: Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.008
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Activation of the unfolded protein response enhances motor recovery after spinal cord injury
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/cddis.2012.8
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Parkinson disease and incidental Lewy body disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002102
    Citation Count: 109
  • Summary Details
    OPEN
    Title: Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
    Journal Name: Behavioural Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbr.2011.12.007
    Citation Count: 145
  • Summary Details
    OPEN
    Title: LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2014.00049
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032
    Citation Count: 71
  • Summary Details
    RESTRICTED
    Title: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2
    Citation Count: 281
  • Summary Details
    OPEN
    Title: Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0043580
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
    Journal Name: Molecular Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1124/mol.108.049551
    Citation Count: 185
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.